High risk factors of atrial fibrillation in type 2 diabetes: Results from the Chinese Kailuan study

QJM: An International Journal of Medicine

Volumn 108, Issue 11, 2015, Pages 885-890

  Ding, X ^a   Zheng, X ^b   Xing, A ^b   Wang, D ^c   Qi, S ^b   Wu, Y ^b   Li, H ^b   Wu, S ^b   Hong, J ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b Hebei Union University   (China)

^c BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; CHINESE; COAL MINING; COMPARATIVE STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE PRESSURE; SEX DIFFERENCE; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS; URIC ACID BLOOD LEVEL; AGED; CHINA; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CHINA; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES; URIC ACID; YOUNG ADULT;

EID: 84949231232     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcv051     Document Type: Article

References (34)

1. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362:1090-101.
2. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study. JAMA 1994; 271:840-4.
3. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 2005; 105:315-18.
4. Huxley RR, Alonso A, Lopez FL, Filion KB, Agarwal SK, Loehr LR, et al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the atherosclerosis risk in communities study. Heart 2012; 98:133-8.
5. Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care 2009; 32:1851-6.
6. Sun GZ, Guo L, Wang XZ, Song HJ, Li Z, Wang J, et al. Prevalence of atrial fibrillation and its risk factors in rural China: a cross-sectional study. Int J Cardiol 2014; 182C:13-17.
7. Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, et al. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J 2009; 30:1128-35.
8. Otake H, Suzuki H, Honda T, Maruyama Y. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart. Int Heart J 2009; 50:627-41.
9. Lip GY, Varughese GI. Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links. Int J Cardiol 2005; 105:319-21.
10. Girerd N, Pibarot P, Fournier D, Daleau P, Voisine P, O'Hara G, et al. Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur Heart J 2009; 30:1270-8.
11. Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 2009; 119:2146-52.
12. Yap KB, Ng TP, Ong HY. Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: a population-based study. J Electrocardiol 2008; 41: 94-8.
13. Li Y, Wu YF, Chen KP, Li X, Zhang X, Xie GQ, et al. Prevalence of atrial fibrillation in China and its risk factors. Biomed Environ Sci 2013; 26:709-16.
14. Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of Mainland China. J Epidemiol 2008; 18:209-16.
15. Yu K, Xing A, Wang D, Qi S, Wang G, Chen R, et al. Prevalence and relative risk factors of atrial fibrillation in male coal miners in North China. Int J Cardiol 2014; 174: 223-4.
16. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European society of cardiology (ESC). Eur Heart J 2010; 31: 2369-429.
17. Sakabe K, Fukuda N, Nada T, Shinohara H, Tamura Y, Wakatsuki T, et al. Age-related changes in the electrophysiologic properties of the atrium in patients with no history of atrial fibrillation. Jpn Heart J 2003; 44:385-93.
18. Lopez FL, Agarwal SK, Maclehose RF, Soliman EZ, Sharrett AR, Huxley RR, et al. Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol 2012; 5:155-62.
19. Alonso A, Yin X, Roetker NS, Magnani JW, Kronmal RA, Ellinor PT, et al. Blood lipids and the incidence of atrial fibrillation: the multi-ethnic study of atherosclerosis and the Framingham heart study. J Am Heart Assoc 2014; 3: e001211.
20. Letsas KP, Korantzopoulos P, Filippatos GS, Mihas CC, Markou V, Gavrielatos G, et al. Uric acid elevation in atrial fibrillation. Hellenic J Cardiol 2010; 51:209-13.
21. Zhao QY, Yu SB, Huang H, Cui HY, Qin M, Huang T, et al. Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure. Chin Med J 2012; 125: 1708-12.
22. Valbusa F, Bertolini L, Bonapace S, Zenari L, Zoppini G, Arcaro G, et al. Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. Am J Cardiol 2013; 112:499-504.
23. Pasalic D, Marinkovic N, Feher-Turkovic L. Uric acid as one of the important factors in multifactorial disorders-facts and controversies. Biochem Med 2012; 22:63-75.
24. Chuang SY, Wu CC, Hsu PF, Chia-Yu Chen R, Liu WL, Hsu YY, et al. Hyperuricemia and incident atrial fibrillation in a normotensive elderly population in Taiwan. Nutr Metab Cardiovasc Dis 2014; 24:1020-6.
25. Negi S, Sovari AA, Dudley SC Jr. Atrial fibrillation: the emerging role of inflammation and oxidative stress. Cardiovasc Hematol Disord Drug Targets 2010; 10:262-8.
26. Marcus GM, Smith LM, Ordovas K, Scheinman MM, Kim AM, Badhwar N, et al. Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm 2010; 7:149-54.
27. Larstorp AC, Ariansen I, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, et al. Association of pulse pressure with newonset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension 2012; 60:347-53.
28. Mitchell GF, Vasan RS, Keyes MJ, Parise H, Wang TJ, Larson MG, et al. Pulse pressure and risk of new-onset atrial fibrillation. JAMA 2007; 297:709-15.
29. Valbusa F, Bonapace S, Bertolini L, Zenari L, Arcaro G, Targher G. Increased pulse pressure independently predicts incident atrial fibrillation in patients with type 2 diabetes. Diabetes Care 2012; 35:2337-9.
30. Watanabe H, Tanabe N, Yagihara N, Watanabe T, Aizawa Y, Kodama M. Association between lipid profile and risk of atrial fibrillation. Circ J 2011; 75:2767-74.
31. He Y, Yang X. A case-control study of screening out risk factors for atrial fibrillation. Chin Circ J 2005; 2:114-7.
32. Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012; 60:2263-70.
33. Osman R, L'Allier PL, Elgharib N, Tardif JC. Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vasc Health Risk Manag 2006; 2:221-37.
34. Azarbal F, Stefanick ML, Salmoirago-Blotcher E, Manson JE, Albert CM, LaMonte MJ, et al. Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. J Am Heart Assoc 2014; 3:e001127.